- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07812363
Titanium Versus Nano-Carbon CAD/CAM Frameworks for All-on-4 Implant Supported Hybrid Prosthesis.
Titanium Versus Nano-Carbon CAD/CAM Frameworks for All-on-4 Implant Supported Hybrid Prosthesis. A Study of Peri-implant Tissue Changes and Prosthetic Complications
This clinical study compares two CAD/CAM framework materials, titanium and nano-carbon fiber-reinforced composite, used in mandibular All-on-4 implant-supported hybrid prostheses. Patients are randomly allocated into two equal groups, with 10 patients in each group. The study evaluates peri-implant soft tissue health, changes in marginal bone levels, and prosthetic complications overa12-month follow-up period.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Completely edentulous patients receive four mandibular implants according to the All-on-4 concept, with two anterior axial implants and two posterior tilted implants placed anterior to the mental foramina. Patients are randomly allocated to receive either a CAD/CAM-milled titanium framework or a nano-carbon fiber-reinforced framework. Clinical follow-up includes assessment of modified plaque index, modified gingival index, probing depth, and bleeding index. Marginal bone level changes are assessed radiographically at 6 and 12 months after insertion of the fixed prosthesis. Prosthetic complications are also evaluated.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Dakahlia Governorate
-
Al Mansurah, Dakahlia Governorate, Egypt
- Faculty of Dentistry, Mansoura University
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
- Voksen
- Eldre voksen
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
-
* Completely edentulous patients requiring mandibular implant-supported rehabilitation.
- Adequate bone quantity and quality in the mandibular interforaminal region for implant placement.
- Adequate restorative space for an implant-supported hybrid prosthesis.
- Healthy oral mucosa and acceptable oral hygiene.
- Patients medically fit to undergo implant surgery.
- Ability and willingness to attend the scheduled follow-up visits and provide informed consent.
Exclusion Criteria:
- Systemic conditions or medical contraindications that could interfere with implant surgery or healing.
- History of radiotherapy to the head and neck region.
- Smoking.
- Alcohol abuse.
- Bruxism or clenching habits.
- Any local condition that could compromise implant placement or the planned prosthetic rehabilitation.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Aktiv komparator: Titanium Framework Group
Participants received mandibular All-on-4 implant-supported hybrid prostheses fabricated with a CAD/CAM-milled titanium framework. |
CAD/CAM-milled titanium framework used for mandibular All-on-4 implant-supported hybrid prosthesis. |
|
Eksperimentell: Nano-Carbon Framework Group
Participants received mandibular All-on-4 implant-supported hybrid prostheses fabricated with a Nano-carbon fiber-reinforced CAD/CAM framework. |
Nano-carbon fiber-reinforced CAD/CAM framework used for mandibular All-on-4 implant-supported hybrid prosthesis. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Marginal bone level change
Tidsramme: At prosthesis insertion (T0), 6 months (T6), and 12 months (T12)
|
Radiographic assessment of changes in peri-implant marginal bone level around the implants in the titanium and nano-carbon framework groups. |
At prosthesis insertion (T0), 6 months (T6), and 12 months (T12)
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Modified plaque index
Tidsramme: At prosthesis insertion (T0), 6 months (T6), and 12 months (T12)
|
Assessment of plaque accumulation around the implants using the modified plaque index |
At prosthesis insertion (T0), 6 months (T6), and 12 months (T12)
|
|
Modified gingival index
Tidsramme: At prosthesis insertion (T0), 6 months (T6), and 12 months (T12)
|
Assessment of peri-implant gingival tissue condition using the modified gingival index |
At prosthesis insertion (T0), 6 months (T6), and 12 months (T12)
|
|
Probing depth
Tidsramme: At prosthesis insertion (T0), 6 months (T6), and 12 months (T12)
|
Measure of per-implant probing depth around the implants |
At prosthesis insertion (T0), 6 months (T6), and 12 months (T12)
|
|
Bleeding index
Tidsramme: At prosthesis insertion (T0), 6 months (T6), and 12 months (T12)
|
Assessment of peri-implant bleeding using the bleeding index |
At prosthesis insertion (T0), 6 months (T6), and 12 months (T12)
|
|
prosthetic complications
Tidsramme: up to12 months after prosthesis insertion
|
Assessment of prosthetic complications and maintenance requirements associated with the implant supported prosthesis |
up to12 months after prosthesis insertion
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- A0102024RP
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Individual participant data are not planned to be shared because the study was conducted as part of an academic doctoral research project and no data-sharing plan was established in the approved protocol.
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .